New Century Healthcare Holding Co. Limited (HKG:1518)
Hong Kong · Delayed Price · Currency is HKD 0.5400
0.00 (0.00%)
At close: Mar 27, 2026
HKG:1518 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 600.1 | 846.5 | 933.07 | 636.46 | 632.57 | |
Revenue Growth (YoY) | -29.11% | -9.28% | 46.60% | 0.62% | 23.36% |
Cost of Revenue | 424.22 | 501.54 | 525.99 | 434.32 | 433.83 |
Gross Profit | 175.88 | 344.96 | 407.09 | 202.14 | 198.74 |
Selling, General & Admin | 184.73 | 192.73 | 198.15 | 194.11 | 217.24 |
Research & Development | 3.31 | 4.08 | 5.93 | 7.7 | 10.57 |
Other Operating Expenses | -0.66 | -0.39 | -1.95 | -3.29 | -3.66 |
Operating Expenses | 187.38 | 202.22 | 211 | 325.16 | 231.74 |
Operating Income | -11.5 | 142.74 | 196.09 | -123.02 | -33 |
Interest Expense | -7.4 | -7.61 | -8.06 | -10.06 | -13.9 |
Interest & Investment Income | - | 4.9 | 1.78 | 2.07 | 3.06 |
Earnings From Equity Investments | 1.16 | 2.27 | -0.08 | -0.03 | -0.7 |
Currency Exchange Gain (Loss) | - | 0.51 | 1.15 | 7.64 | -2.35 |
Other Non Operating Income (Expenses) | 2.69 | -0.5 | -0.46 | -2.97 | -0.4 |
EBT Excluding Unusual Items | -15.03 | 142.31 | 190.43 | -126.36 | -47.3 |
Impairment of Goodwill | - | - | - | -33.6 | - |
Gain (Loss) on Sale of Investments | - | - | - | -7.86 | - |
Gain (Loss) on Sale of Assets | - | -0.77 | -0.72 | 0.07 | 3.16 |
Asset Writedown | -59.51 | - | -23.56 | -122.1 | -15.01 |
Pretax Income | -74.54 | 141.54 | 166.14 | -289.85 | -59.15 |
Income Tax Expense | 24.57 | 47.76 | 34.05 | 1.72 | 26.12 |
Earnings From Continuing Operations | -99.11 | 93.78 | 132.09 | -291.57 | -85.26 |
Minority Interest in Earnings | -16.2 | -46.4 | -47.93 | -6.16 | -16.2 |
Net Income | -115.31 | 47.38 | 84.16 | -297.73 | -101.46 |
Net Income to Common | -115.31 | 47.38 | 84.16 | -297.73 | -101.46 |
Net Income Growth | - | -43.71% | - | - | - |
Shares Outstanding (Basic) | 480 | 483 | 483 | 483 | 483 |
Shares Outstanding (Diluted) | 480 | 483 | 483 | 483 | 483 |
Shares Change (YoY) | -0.56% | - | -0.01% | -0.02% | -0.37% |
EPS (Basic) | -0.24 | 0.10 | 0.17 | -0.62 | -0.21 |
EPS (Diluted) | -0.24 | 0.10 | 0.17 | -0.62 | -0.21 |
EPS Growth | - | -43.71% | - | - | - |
Free Cash Flow | - | 114.33 | 149.43 | 66.63 | 11.02 |
Free Cash Flow Per Share | - | 0.24 | 0.31 | 0.14 | 0.02 |
Dividend Per Share | - | 0.021 | 0.034 | - | - |
Dividend Growth | - | -39.47% | - | - | - |
Gross Margin | 29.31% | 40.75% | 43.63% | 31.76% | 31.42% |
Operating Margin | -1.92% | 16.86% | 21.02% | -19.33% | -5.22% |
Profit Margin | -19.21% | 5.60% | 9.02% | -46.78% | -16.04% |
Free Cash Flow Margin | - | 13.51% | 16.01% | 10.47% | 1.74% |
EBITDA | 12.79 | 167.02 | 224.04 | -87.54 | 10.22 |
EBITDA Margin | 2.13% | 19.73% | 24.01% | -13.75% | 1.62% |
D&A For EBITDA | 24.28 | 24.28 | 27.95 | 35.48 | 43.22 |
EBIT | -11.5 | 142.74 | 196.09 | -123.02 | -33 |
EBIT Margin | -1.92% | 16.86% | 21.02% | -19.33% | -5.22% |
Effective Tax Rate | - | 33.74% | 20.50% | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.